Population Pharmacokinetics of Linezolid in Adults with Pulmonary Tuberculosis

Antimicrobial Agents and Chemotherapy
2009.0

Abstract

Nineteen adults with pulmonary tuberculosis received linezolid (600 mg) once or twice daily in an early bactericidal activity trial. A one-compartment population model produced median values for the absorption rate constant, volume of distribution, and elimination rate constant of 1.5 h(-1), 29.6 liters, and 0.25 h(-1) (once daily) and 2.7 h(-1), 32.1 liters, and 0.15 h(-1) (twice daily). Linezolid administered twice daily produced higher values for free drug area under the concentration-time curve (AUC)/MIC and time above MIC. Both regimens achieved free AUC/MIC ratios > 100. Median times above the MIC for free drug were 100% (twice daily) and 63% (once daily).

Knowledge Graph

Similar Paper

Population Pharmacokinetics of Linezolid in Adults with Pulmonary Tuberculosis
Antimicrobial Agents and Chemotherapy 2009.0
Population Pharmacokinetics of Levofloxacin, Gatifloxacin, and Moxifloxacin in Adults with Pulmonary Tuberculosis
Antimicrobial Agents and Chemotherapy 2008.0
Use of an In Vitro Pharmacodynamic Model To Derive a Linezolid Regimen That Optimizes Bacterial Kill and Prevents Emergence of Resistance in Bacillus anthracis
Antimicrobial Agents and Chemotherapy 2008.0
Population Modeling and Monte Carlo Simulation Study of the Pharmacokinetics and Antituberculosis Pharmacodynamics of Rifampin in Lungs
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro Activities of Linezolid against Clinical Isolates of Mycobacterium tuberculosis Complex Isolated in Taiwan over 10 Years
Antimicrobial Agents and Chemotherapy 2008.0
Pharmacokinetic/Pharmacodynamic Factors Influencing Emergence of Resistance to Linezolid in an In Vitro Model
Antimicrobial Agents and Chemotherapy 2007.0
Population Pharmacokinetics of Rifampin in Pulmonary Tuberculosis Patients, Including a Semimechanistic Model To Describe Variable Absorption
Antimicrobial Agents and Chemotherapy 2008.0
Therapeutic Drug Monitoring of Linezolid: a Retrospective Monocentric Analysis
Antimicrobial Agents and Chemotherapy 2010.0
Pharmacodynamics of Minocycline against Staphylococcus aureus in an In Vitro Pharmacokinetic Model
Antimicrobial Agents and Chemotherapy 2008.0
Activity of Linezolid in anIn VitroPharmacokinetic-Pharmacodynamic Model Using Different Dosages andStaphylococcus aureusandEnterococcus faecalisStrains with and without a Hypermutator Phenotype
Antimicrobial Agents and Chemotherapy 2010.0